For the Inventor, By the Inventor

Enter assignee name

Abingdon Oxon, United Kingdom

Oxagen Limited

USPTO Granted Patents = 12

EPO Patents = 1

Forward Citations = 149

Loading Chart...

Loading Chart...

18 inventors (with patents filed for the assignee):

Mark Whittaker (7 out of 17 patents)

Eric Roy Pettipher (7 out of 10 patents)

Richard Edward Armer (6 out of 11 patents)

4. Edward Andrew Boyd (6 out of 33 patents)

5. Frederick Arthur Brookfield (5 out of 64 patents)

6. Graham Michael Wynne (5 out of 14 patents)

7. David Middlemiss (5 out of 5 patents)

8. Mark Richard Ashton (5 out of 9 patents)

9. Michael George Hunter (5 out of 5 patents)

10. Chris Palmer (5 out of 5 patents)

11. Colin Richard Dorgan (3 out of 10 patents)

12. Julia Vile (3 out of 8 patents)

13. Peter David Johnson (2 out of 28 patents)

14. Frank Schroer (2 out of 5 patents)

15. Carole Eliane Andree Maillol (1 out of 1 patent)

12 patents: Sort by Forward Citations

1. 8314257 - Treatment of CRTH2-mediated diseases and conditions (2012-11-20),

2. 8268878 - Compounds having CRTH2 antagonist activity (2012-09-18),

3. 8198314 - Treatment of CRTH2-mediated diseases and conditions (2012-06-12),

4. 8168673 - Compounds having CRTH2 antagonist activity (2012-05-01),

5. 8163936 - Treatment of CRTH2-mediated diseases and conditions (2012-04-24),

6. 8163931 - Treatment of CRTH2-mediated diseases and conditions (2012-04-24),

7. 8044088 - 1-acetic acid-indole derivatives with PGD2 antagonist activity (2011-10-25),

8. 7999119 - Compounds having CRTH2 antagonist activity (2011-08-16),

9. 7919512 - Compounds having CRTH2 antagonist activity (2011-04-05),

10. 7750027 - Compounds having CRTH2 antagonist activity (2010-07-06),

11. 7582672 - Compounds for the treatment of CRTH2-mediated diseases and conditions (2009-09-01),

12. 7521194 - Method for detection of MIP-4 and CCRL2 binding and activity modulating agents (2009-04-21),

Oxagen Limited is a leading biopharmaceutical company focused on the research, development, and commercialization of innovative therapies for respiratory diseases. Our dedicated team of scientists and researchers work tirelessly to discover and advance novel approaches to improve the lives of patients suffering from serious respiratory conditions. With a strong emphasis on sustainability and patient-centric innovation, Oxagen Limited is committed to delivering therapies that address significant unmet medical needs in the field of respiratory medicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

12 Patents

#1 in Abingdon Oxon

#1,438 in United Kingdom

#46,735 in the World

Abingdon Oxon, United Kingdom

Oxagen Limited

Forward Citations = 149

18 inventors:

Mark Whittaker (7 out of 17 patents)

Eric Roy Pettipher (7 out of 10 patents)

Richard Edward Armer (6 out of 11 patents)

4. Edward Andrew Boyd (6 out of 33 patents)

5. Frederick Arthur Brookfield (5 out of 64 patents)

Please report any incorrect information to support@idiyas.com

Loading…